Publications/Presentations

PUBLICATIONS

(Post-Baccalaureate co-authors indicated by an ‡; Undergraduate co-authors underlined; High school co-authors indicated by an *) 

  1. The Benefits of Enlightenment: A Strategic Pedagogy for Explicitly Teaching about Diversity and Equity in STEM Classrooms. Stoddard SV. Education Sciences, 2022, 12(7),498 Link
     
  2. In silico design of peptide-based SARS-CoV-2 fusion inhibitors that target WT and mutant versions of SARS-CoV-2 HR1 domains. Stoddard SV, Wallace FE*, Stoddard SD‡, Cheng Q, Acosta D, Barzani S, Bobay M, Briant J, Cisneros C, Feinstein S, Glasper K, Hussain M, Lidoski A, Lingareddy P, Lovett G, Matherne L, McIntosh J, Moosani N, Nagge L, Nyamkondiwa K, Pratt I, Root E, Rutledge MR, Sawyer M, Singh Y, Smith K, Tanveer U, and Vaghela S.  Biophysica, 2021, 1(3), 311-327 Link
     
  3. Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site. Stoddard SV, Stoddard SD, Oelkers BK, Fitts K, Whalum K1, Whalum K2, Hemphill AD, Manikonda J, Martinez LM, Riley EG, Roof CM, Sarwar N, Thomas DM, Ulmer E, Wallace FE*, Pandey P, and Roy S. Viruses, (2020), 12, 942 Link
     
  4. Design and Synthesis of Diazine-based Panobinostat Analogues for HDAC8 Inhibition. Balasubramaniam S, Vijayan S, Goldman L, May XA, Dodson K, Adhikari S, Rivas F, Watkins DL, and Stoddard SV.  Beilstein Journal of Organic Chemistry (2020) 16, 628-637  Link
     
  5. In silico Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity. Stoddard SV, Dodson K, Adams K, Wadkins DL. International Journal of Molecular Science (2020) 21(1), 219 Link
     
  6. Variable In Vivo Expression of Disiaganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma Determined Using Positron Emission Tomography. 7. Butch ER, Mead PE, Amador-Diaz V, Tillman H, Stewart E, Mishra JK, Kim J, Bahrami A, Dearling JLJ, Packard AB, Stoddard SV, Vāvere AL, Han Y, Shulkin BL, and Snyder SE. Cancer Research (2019) 79: 1-13; Link
     
  7. Structure and Function Insights Garnered from In silico Modelling of the Thrombospondin Type-1 Domain-Containing 7A Antigen. Stoddard SV, Welsh CL, Palopoli MM, Stoddard SD, Aramandla MP, Patel RM, and Beck, Jr. LH PROTEINS: Structure, Function, Bioinformatics.  Proteins. (2019) 87(2) 136-145 Link
     
  8. Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between Histone Deacetylase 2 (HDAC2) and Histone Deacetylase 8 (HDAC8) Stoddard SV, May XA, Rivas F, Dodson K, Vijayan S, Adhika S, Parker K, Watkins DL. Molecular Informatics (2018) 38(3) 1800080; Link
     
  9. Insights and Ideas Garnered from Marine Metabolites for Development of Acetylcholinesterase and Amyloid-β Aggregation Inhibitors, Stoddard SV, Hamann MT, Wadkins RM. Marine Drugs (2014) 12, 2114-2131; Link
     
  10. In Silico Design and Evaluation of Carboxylesterase Inhibitors, Stoddard SV, Yu X, Potter PM, Wadkins RM. Journal of Pesticide Science (2010) 35, 240-249; Link
     
  11. Improved, Selective, Human Intestinal Carboxylesterase Inhibitors Designed to Modulate CPT-11 Toxicity, Hicks LD, Hyatt JL, Stoddard SV, Tsurkan L, Edward CC, Wierdl M, Wadkins RM, Potter PM. Journal of Medicinal Chemistry (2009) 52, 3742-3752; Link

SELECTED PRESENTATIONS

  1. Stoddard SV Harnessing molecular interactions for the design of biotools to advance study of extracellular matrix reorganization and design of and antiviral therapeutics targeting COVID-19. Invited Talk, Trinity College, Hartford, CT (May 2022)
     
  2. Stoddard SV Harnessing molecular interactions for the design of biotools to advance study of extracellular matrix reorganization and design of and antiviral therapeutics targeting COVID-19 Invited Talk, University of Mississippi, Oxford, MS (April 2022)
     
  3. Scott Z‡, Glasper K‡, Tiwari A, and Stoddard SV. Development of broad-spectrum inhibitors targeting the N-NTD of coronaviruses: optimization guidelines for antiviral therapeutic interventions of COVID-19 and related diseases, National Organization for the Professional Advancement of Black Chemists and Chemical Engineers 1st Annual Southeast/Southwest Regional Meeting; Oxford, MS (April 2022) 
     
  4. Luthcke N and Stoddard SV Modeling, Characterization and Analysis of Human WNT1-inducible-signalling pathway and Netrin receptor protein. Southeastern Regional Meeting of the American Chemical Society; Charlotte, NC (November 2021)
     
  5. Stoddard SV and Stoddard CN, The Benefits of Enlightenment?: A Strategic Pedagogy for Explicitly Teaching about Diversity and Equity in STEM Classrooms. American Chemical Society, Oral talk (April 2021)
     
  6. Russ A, Oelkers B, Wallace FE*, Stoddard SD, Cheng Q, and Stoddard SV. Protein engineering and optimization of peptide-based therapeutics as RBD binding coronavirus antivirals. American Chemical Society (April 2021)
     
  7. Wallace FE*, Stoddard SD‡, Russ A, Oelkers B, Cheng Q, and Stoddard SV. Protein engineering and optimization of peptide-based therapeutics as HR1 binding coronavirus antivirals. American Chemical Society (April 2021)
     
  8. Whalum K, Edwards K, Cheng Q, Stoddard SD‡, Calderon G, Luthcke N, Kasetty K, and Stoddard SV. Modeling, Characterization, and Classification of Human Thrombospondin Type-1 Like Domains: Evidence for TRP Ladder Functionalization Based on Ladder Type? American Chemical Society (April 2021)
     
  9. Moses A, Kemp A, Glasper K, Fitts K, James B, Goldman L, May X, and Stoddard SV. Developing the perfect fit: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitors for Anti-cancer, Neurological and Autoimmune Therapies. American Chemical Society (April 2021)
     
  10. Kemp A, Moses A, Glasper K, Fitts K, James B, Goldman L, May X, and Stoddard SV. Developing the perfect fit: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitors for Anti-cancer, Neurological and Autoimmune Therapies. National Conference on Undergraduate Research. Bozeman, MT (April 2021)
     
  11. Kasetty K, Edwards K, Cheng Q, Stoddard SD‡, Calderon G, Luthcke N, Whalum K, and Stoddard SV. Modeling, Characterization, and Classification of Human Thrombospondin Type-1 Like Domains: Evidence for TRP Ladder Functionalization Based on Ladder Type? National Conference on Undergraduate Research; Bozeman, MT (April 2021)
     
  12. Oelkers B, Wallace FE*, Russ A, Stoddard SD‡, Cheng Q, and Stoddard SV. Protein engineering and optimization of peptide-based therapeutics as dual site binding coronavirus antivirals National Conference on Undergraduate Research; Bozeman, MT (April 2021)
     
  13. Stoddard SV, Stoddard SD‡, Oelkers BK, Fitts K, Whalum K1, Whalum K2, Hemphill AD, Manikonda J, Martinez LM, Riley EG, Roof CM, Sarwar N, Thomas DM, Ulmer E, Wallace FE*, Pandey P, and Roy S, Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site. National Conference on Undergraduate Research; Bozeman, MT (April 2021)
     
  14. Stoddard SV Molecular Immunotherapeutics Research: Advances in Autoimmnue, Anticancer, and Antiviral Therapeutics. Invited Talk, University of Memphis, Memphis, TN (November 2020)
     
  15. Thelven J, Goldman L, Stoddard SV, de la Salud Bea R. Design, Synthesis, and Effect of Diarylcyclopropane hydroxamic Acids as Histone Deacetylase (HDAC) Inhibitors: Improving Possible Therapy for Huntington’s disease. 46th ACS National Organic Symposium; Bloomington, IN (June 2019)
     
  16. Welsh C and Stoddard SV. In silico Prediction of Immunogenic Sites on PMN Antigen and Design of Epitope Blocking Caps. American Society for Biochemistry and Molecular Biology Annual National Meeting; Orlando, FL (April 2019)
     
  17. Stoddard SD and Stoddard SV. New tools for autoimmune kidney disease: Design of antigen binding proteins against the thrombospondin type-1 containing domain 7A. American Society for Biochemistry and Molecular Biology Annual National Meeting; Orlando, FL (April 2019)
     
  18. Stocks O, Goldman L, and Stoddard SV. Development of Antigen Binding Protein Monobodies as a Tool for Antigen Specific Treatment for Autoimmune Kidney Disease. American Society for Biochemistry and Molecular Biology Annual National Meeting; Orlando, FL (April 2019)
     
  19. Goldman L, Stocks O, and Stoddard SV. Epitope Characterization and Design of Epitope Binding Proteins for Idiopathic Membranous Nephropathy: New Tools for Autoimmune Kidney Disease Therapy American Society for Biochemistry and Molecular Biology Annual National Meeting; Orlando, FL (April 2019)
     
  20. Rasasack I and Stoddard SV. Development of antigen-specific blocking monobodies against the β2-glycoprotein I receptor for the inhibition of systemic lupus erythematosus. American Society for Biochemistry and Molecular Biology Annual National Meeting; Orlando, FL (April 2019)
     
  21. Galani A and Stoddard SV. Design of antibody-blocking monobodies: A novel therapeutic approach for autoimmune kidney disease. American Society for Biochemistry and Molecular Biology Annual National Meeting; Orlando, FL (April 2019)
     
  22. Stoddard SD and Stoddard SV. New tools for autoimmune kidney disease. Design of antigen binding proteins against the thrombospondin type-1 containing domain 7A. Annual Biomedical Research Conference for Minority Students; Indianapolis, IN (November 2018)
     
  23. Stoddard SV. Computational Insights into the Structure and Epitope locations for Two Idiopathic Membranous Nephropathy Antigens: Phospholipase A2 Receptor and the Thrombospondin Type-1 Containing Domain 7A and Design of Antigen Binding Proteins. American Society for Biochemistry and Molecular Biology Annual National Meeting; San Diego, CA (April 2018)
     
  24. Rich B, Goldman L, Martin C*, Stoddard SV, Brien KA. Synthesis and Computational Evaluation of Vorinostat Boron Derivatives as Potential Histone Deacetylase Inhibitors. 255th American Chemical Society National Meeting; New Orleans, LA (March 2018)